Pyxis Oncology Inc — Cash Flow (NASDAQ:PYXS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -35.33 M-89.33 M-70.71 M-57.67 M-63.5 M -63.5 M Cash from investing activities -590 K-6.4 M-104.85 M8.15 M58.86 M 58.86 M Cash from financing activities 304.04 M183 K5.93 M59.33 M594 K 592 K Free cash flow -35.87 M-95.73 M-77.44 M-57.91 M-63.51 M -63.5 M

News

Pyxis Oncology appoints Thomas Civik as interim CEO

Pyxis Oncology stock price target raised to $7 by H.C. Wainwright

Analysts Sound Alarm On Pyxis Oncology's Tiny Trial - Pyxis Oncology (NASDAQ:PYXS)

Tesla To $444? Here Are 10 Top Analyst Forecasts For Friday - AGCO (NYSE:AGCO), Assurant (NYSE:AIZ)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

Pyxis Oncology stock falls as RBC cuts price target on complex trial data

Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Transcript

Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma - Slideshow (NASDAQ:PYXS) 2025-12-18

Pyxis Oncology stock plummets after early-stage cancer drug data

Nasdaq Gains Over 200 Points; US Inflation Slows To 2.7% - Actelis Networks (NASDAQ:ASNS), Athira Pharma (NASDAQ:ATHA)

Pyxis Oncology reports positive data for head and neck cancer drug

Dow Surges 400 Points; Accenture Earnings Top Views - Accenture (NYSE:ACN), Actelis Networks (NASDAQ:ASNS)